Successful application of vacuum-assisted closure therapy for treatment of mastitis-associated chronic breast wounds

Archives of Gynecology and Obstetrics
Doerte W LueddersMarc Thill

Abstract

Although non-puerperal mastitis is rare and its cause is rather unclear, the number of patients diagnosed with this defect is increasing. In some cases, standard therapy fails and it progresses to a chronic disease. Vacuum-assisted closure (VAC) therapy has shown good results in healing complex wounds. The goal of this study was to evaluate our experiences with VAC therapy and to answer the question whether or not should be accepted as an effective treatment in healing chronic wounds caused by non-puerperal mastitis. Retrospectively, we identified five patients with a non-puerperal mastitis chronic wound that was treated using VAC and report on their outcome. We reached both wound control and closure of the breast wounds in all patients. According to our findings, the VAC therapy can be considered when managing challenging breast wounds, particularly when other therapeutic options have failed. The role of VAC therapy as a primary therapeutic option has not yet been evaluated.

References

Nov 5, 1977·British Medical Journal·C P Sames
Dec 1, 1988·International Journal of Epidemiology·P SchäferB Mermillod
Mar 20, 2001·British Journal of Plastic Surgery·D Evans, L Land
Mar 15, 2002·Obstetrics and Gynecology Clinics of North America·Douglas J Marchant
Mar 1, 1951·American Journal of Surgery·J J ZUSKAW W AYRES
Jun 7, 2005·Postgraduate Medical Journal·S M JonesP G Shakespeare
Jan 31, 2006·The Breast : Official Journal of the European Society of Mastology·William T StoeckelNancy D Perrier
Jun 1, 2006·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Regina RennerJan C Simon
Dec 14, 2007·Neuro-degenerative Diseases·Joanne L Jones, Alasdair J Coles
Mar 5, 2008·Plastic and Reconstructive Surgery·Aaron S Kendrick, Christopher W Chase

❮ Previous
Next ❯

Citations

Nov 18, 2015·ANZ Journal of Surgery·Farid MeybodiElisabeth Elder
May 30, 2014·Surgical Infections·Efthymios K KostarasMatthew E Falagas

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
M RaoP M Sagar
© 2021 Meta ULC. All rights reserved